| type : |
Artikel |
|
| onderzoeksgroepen : |
Callaghan - School of Pharmacy and Medical Sciences |
| Auteur : |
Sharley NA, Yu AMC, Williams DB. |
| titel : |
Stability of mixtures formulated from warfarin tablets or powder. |
| Nummer : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
| Niveau van bewijs : |
|
| fysische stabiliteit : |
|
| chemische stabiliteit : |
|
| andere methoden : |
|
| Reacties : |
|
Stoffenlijst
 Warfarin sodium
|
 |
 |
 |
 |
300 mg
Coumadin® |
| Natriumfosfaat |
3000 mg |
| tragacanth |
4% 60 ml |
| Sorbitolsiroop |
5% 75 ml |
| methylparaben |
240 mg |
| propylparabeen |
60 mg |
| Propyleenglycol |
3 ml |
| gedestilleerd water |
>> 300 ml |
|
20-24°C |
 |
| 28 |
 |
|
|
|
|
|
300 mg
Marevan® |
| Natriumfosfaat |
3000 mg |
| tragacanth |
4% 60 ml |
| Sorbitolsiroop |
5% 75 ml |
| methylparaben |
240 mg |
| propylparabeen |
60 mg |
| Propyleenglycol |
3 ml |
| gedestilleerd water |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
 |
324.3 mg
Warfarin sodium clathrate |
| Natriumfosfaat |
3000 mg |
| methylparaben |
240 mg |
| propylparabeen |
60 mg |
| Propyleenglycol |
3 ml |
| gedestilleerd water |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
